HomeSKYE • OTCMKTS
Follow
Skye Bioscience Inc
Previous close
$14.34
Day range
$14.34 - $15.75
Year range
$1.44 - $19.41
Market cap
438.90M USD
Avg Volume
43.18K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.49M | 19.45% |
Net income | -24.95M | -697.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.46M | -19.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.13M | 1,134.08% |
Total assets | 15.60M | 443.93% |
Total liabilities | 13.91M | 126.02% |
Total equity | 1.70M | — |
Shares outstanding | 12.34M | — |
Price to book | 102.43 | — |
Return on assets | -97.83% | — |
Return on capital | 1,339.49% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -24.95M | -697.68% |
Cash from operations | -4.05M | -97.16% |
Cash from investing | 1.07M | 393.13% |
Cash from financing | 16.63M | 18,211.45% |
Net change in cash | 13.65M | 642.97% |
Free cash flow | -11.34M | -827.93% |
About
Founded
2011
Website
Employees
11